Gabriele Proetzel

Director, Regenerative Medicine Unit, Takeda Pharmaceutical Company

Gabriele joined Takeda in 2013, as part of the New Frontier Science group focused on finding, developing and integrating foundational technologies into Takeda’s research and development process. During this time she established multiple research collaborations. Currently, Gabriele is Director of Regenerative Medicine.

Previously, Gabriele served as Associate Director for Technology Transfer at The Jackson Laboratory, Chief Scientific  Officer at Scil Proteins GmbH, Germany.  Prior appointments were at Deltagen Inc. USA  and Roche, Germany. She received her Ph.D. from the University of Cincinnati, and a Master from the University of Würzburg, Germany.